Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ekadharma International Tbk. (EKAD) vs Mizuho Leasing Indonesia Tbk. (VRNA) Price & Performance

Ekadharma International Tbk.Trade
Mizuho Leasing Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Ekadharma International Tbk. vs Mizuho Leasing Indonesia Tbk. — how do they compare? Ekadharma International Tbk. trades at Rp326 (market cap 1.05T, 82.72M 24h volume), while Mizuho Leasing Indonesia Tbk. trades at Rp75 (market cap 426.55B, 9.6K 24h volume). The key difference: Ekadharma International Tbk. is far larger — about 2.5× Mizuho Leasing Indonesia Tbk.'s market cap, and Ekadharma International Tbk. is more actively traded (82.72M versus 9.6K). Which is the better fit depends on your goals.

EKADVRNA
Market Cap
1.05T426.55B
Volume
82.72M9.6K
Lot
827.23K96
Turnover
27.99B728.6K
Average Price
338.3775.9
Value
27.99B728.6K
Indicative Equilibrium Price
33076
Indicative Equilibrium Volume
24.68K71

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EKAD
View details
VRNA
View details

About Ekadharma International Tbk.

PT Ekadharma International Tbk (the Company) was established under the name of PT Ekadharma Widya Graphika based on Notarial Deed No. 71 dated November 20, 1981. PT Ekadharma Tape Industries Tbk manufactures computer continuous form paper and other related products. It also holds a manufacturing and distribution license from Nashua Corporation, USA.In August 2, 2006, The company's name was changed to PT Ekadharma International Tbk.

Read more on EKAD

About Mizuho Leasing Indonesia Tbk.

PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.

Read more on VRNA